Results
|
15801.
|
|
|
15802.
|
Immune responses elicited by the GEN-003 candidate HSV-2 therapeutic vaccine in a randomized controlled dose-ranging phase 1/2a trial. [electronic resource] by
- Flechtner, Jessica Baker
- Long, Deborah
- Larson, Shane
- Clemens, Veronica
- Baccari, Amy
- Kien, Lena
- Chan, Jason
- Skoberne, Mojca
- Brudner, Matthew
- Hetherington, Seth
Producer: 20171211
In:
Vaccine vol. 34
Availability: No items available.
|
|
15803.
|
|
|
15804.
|
|
|
15805.
|
Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1. [electronic resource] by
- Wang, Kening
- Tomaras, Georgia D
- Jegaskanda, Sinthujan
- Moody, M Anthony
- Liao, Hua-Xin
- Goodman, Kyle N
- Berman, Phillip W
- Rerks-Ngarm, Supachai
- Pitisuttithum, Punnee
- Nitayapan, Sorachai
- Kaewkungwal, Jaranit
- Haynes, Barton F
- Cohen, Jeffrey I
Producer: 20170926
In:
Journal of virology vol. 91
Availability: No items available.
|
|
15806.
|
|
|
15807.
|
|
|
15808.
|
|
|
15809.
|
|
|
15810.
|
|
|
15811.
|
|
|
15812.
|
|
|
15813.
|
|
|
15814.
|
|
|
15815.
|
|
|
15816.
|
|
|
15817.
|
|
|
15818.
|
|
|
15819.
|
|
|
15820.
|
|